“OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 7, no. 1, Jan. 2015, p. e2015003, https://doi.org/10.4084/mjhid.2015.003.